In this episode of our podcast, we explore a study published in The New England Journal of Medicine, detailing the effects of semaglutide on patients with heart failure and type 2 diabetes. Our podcast provides valuable insights into the study's implications, the benefits of semaglutide, and what the future might hold for managing these complex conditions.

Kosiborod, M. N., Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Hovingh, G. K., ... & Shah, S. J. (2024). Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. *The New England Journal of Medicine*. https://doi.org/10.1056/NEJMoa2313917